Retrospective Study
Copyright ©The Author(s) 2016.
World J Gastrointest Endosc. Dec 16, 2016; 8(20): 763-769
Published online Dec 16, 2016. doi: 10.4253/wjge.v8.i20.763
Table 4 Studies evaluating endoscopic management of T1b esophageal adenocarcinoma
Ref.# PatientsDepth of invasionHistologyMarginsRemissionRecurrenceSurvival
Manner et al[12]21sm1Well to moderately differentiated, no lymphovascular invasionLateral margins negative in 1295% at mean 5.3 mo28% at mean 62 mo (range 45-89)67% estimated 5-yr survival
Alvarez Herrero et al[14]18sm1 and sm2/3Well, moderately and poorly differentiated, some with lymphovascular invasionNot reportedNot reported17%Not reported
Tian et al[15]29sm1 and sm2-3Not reportedNot reportedNot reportedNot reported62% with median duration 34.8 mo
Manner et al[13]66sm1Well to moderately differentiated, no lymphovascular invasionNot reported84% at mean 4.5 mo21% at mean 22 mo (range 6-60)84% estimated 5-yr survival